Related Experiment Video

Updated: Aug 16, 2026

In Vitro Model of Human Cutaneous Hypertrophic Scarring using Macromolecular Crowding
08:20

In Vitro Model of Human Cutaneous Hypertrophic Scarring using Macromolecular Crowding

Published on: May 1, 2020

[Microvessel counts and the expressions of chemotactic factors in the pathological scar tissues]

Li Qian1, Bai-Cheng Zhao, Li Pi

  • 1Department of Burn and Plastic Surgery, Second Xiangya Hospital, Central South University, Changsha 410011, China. HNFIJ@163.com

Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences
|July 28, 2005
PubMed
Abstract

Insights

Pathological scars exhibit increased microvessel density and elevated levels of interleukin-8 (IL-8), monocyte chemoattractant protein-1 (MCP-1), and macrophage inflammatory protein-1 alpha (MIP-1alpha) mRNA. These factors promote neovascularization in scar tissue.

Area of Science:

  • Dermatology
  • Pathology
  • Molecular Biology

Context:

  • Pathological scars, such as hypertrophic scars and keloids, represent a significant clinical challenge.
  • Neovascularization is a key process in scar formation and maturation.
  • The role of specific inflammatory mediators in scar-related angiogenesis requires further elucidation.

Purpose:

  • To investigate the correlation between microvessel density and the expression of IL-8, MCP-1, and MIP-1alpha mRNA in pathological scar tissues.
  • To compare these markers in pathological scars versus normal and surgical scars.

Summary:

  • Microvessel counts and mRNA expression levels of IL-8, MCP-1, and MIP-1alpha were significantly higher in pathological scars compared to normal and surgical scars.
  • Positive correlations were observed between microvessel counts and the expression of these three inflammatory markers.
  • Higher microvessel counts were noted in younger hypertrophic scars (<1 year) compared to older ones (>1 year).

Impact:

  • The findings suggest that IL-8, MCP-1, and MIP-1alpha are crucial in promoting neovascularization within pathological scars.
  • This research provides insights into the molecular mechanisms underlying scar development.
  • Potential therapeutic strategies targeting these mediators could be explored for managing pathological scars.

More Related Videos

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells09:03

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Published on: November 23, 2014

Investigating Angiogenesis on a Functional and Molecular Level by Leveraging the Scratch Wound Migration Assay and the Spheroid Sprouting Assay09:16

Investigating Angiogenesis on a Functional and Molecular Level by Leveraging the Scratch Wound Migration Assay and the Spheroid Sprouting Assay

Published on: May 31, 2024

Related Concept Videos

Healing II: Complications01:24

Healing II: Complications

Complications during healing arise when tissue repair is altered by local or systemic factors. These changes involve abnormal collagen deposition, altered biomechanics, and reduced vascular supply, impairing restoration of normal structure and function.Loss of FunctionScar tissue differs significantly from the original tissue it replaces. In the skin, fibrosis lacks adnexal structures such as hair follicles, sebaceous glands, and sweat glands. Their absence reduces tactile sensitivity, impairs...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...